Comparative evaluation of a new immunoradiometric assay for corticotropin. Clin Chem Lab Med 2006;44(5):669-71
Date
05/10/2006Pubmed ID
16681443DOI
10.1515/CCLM.2006.113Scopus ID
2-s2.0-33646699125 (requires institutional sign-in at Scopus site) 14 CitationsAbstract
We have characterized the performance of a commercial two-site immunoradiometric assay for manual in vitro diagnostic measurement of plasma corticotropin from Scantibodies Laboratory. We compared the results with those of a similar commonly used assay from Nichols Institute Diagnostics that has recently been withdrawn from production. The lower detection limit, range of the standard curve, cross-reactivity, and intra-assay and inter-assay imprecision of the two assays are very similar. Measurement of clinical samples and a series of samples from an experimental subject demonstrate high correlations between the two assays. These factors, together with recent clearance by the United States Food and Drug Administration for manual in vitro diagnostic measurement, make the Scantibodies corticotropin immunoradiometric assay an appropriate replacement for the Nichols assay.
Author List
Wilkinson CW, Raff HAuthor
Hershel Raff PhD Professor in the Academic Affairs department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Adrenocorticotropic HormoneChemistry, Clinical
Dose-Response Relationship, Drug
Evaluation Studies as Topic
Humans
Immunoradiometric Assay
Regression Analysis
Reproducibility of Results
Sensitivity and Specificity
Time Factors